| 000 | 01859 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515135621.0 | ||
| 264 | 0 | _c20090810 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1873-5126 | ||
| 024 | 7 |
_a10.1016/j.parkreldis.2008.07.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHasegawa, Kazuko | |
| 245 | 0 | 0 |
_aFamilial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. _h[electronic resource] |
| 260 |
_bParkinsonism & related disorders _cMay 2009 |
||
| 300 |
_a300-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3-Iodobenzylguanidine |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aFamily Health |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoleucine _xgenetics |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aLeucine-Rich Repeat Serine-Threonine Protein Kinase-2 |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xdiagnostic imaging |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 |
_aTetrabenazine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTyrosine _xgenetics |
| 700 | 1 | _aStoessl, A Jon | |
| 700 | 1 | _aYokoyama, Teruo | |
| 700 | 1 | _aKowa, Hisayuki | |
| 700 | 1 | _aWszolek, Zbigniew K | |
| 700 | 1 | _aYagishita, Saburo | |
| 773 | 0 |
_tParkinsonism & related disorders _gvol. 15 _gno. 4 _gp. 300-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.parkreldis.2008.07.010 _zAvailable from publisher's website |
| 999 |
_c18272140 _d18272140 |
||